Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Some breast cancer chemotherapy can cause permanent hair loss.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.

New treatments for male hypogonadism are effective and should be personalized.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Treating hyperprolactinemia can help manage PCOS symptoms.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.